This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pentikäinen, M. O. Articles by Kovanen, P. T. Search for Related Content PubMed PubMed Citation Articles by Pentikäinen, M. O. Articles by Kovanen, P. T.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:740-747.)
© 1995 American Heart Association, Inc.

Articles

Inhibition of the Oxidative Modification of LDL by Nitecapone

Markku O. Pentikäinen; Ken A. Lindstedt; Petri T. Kovanen

From the Wihuri Research Institute, Helsinki, Finland.

Correspondence to Petri T. Kovanen, Wihuri Research Institute, Kalliolinnantie 4, SF-00140 Helsinki, Finland.

Abstract We studied in vitro the ability of nitecapone, 3-[(3,4-dihydroxy-5-nitrophenyl)methylene]-2,4-pentanedione, a novel water-soluble compound with antioxidative properties, to inhibit the LDL oxidation promoted by copper ions, the aqueous free radical generator 2,2'-azobis(2-amidinopropane) hydrochloride (AAPH), and mouse peritoneal macrophages. In these three oxidation systems, the extent of LDL oxidation was determined by measuring the formation of conjugated dienes, the formation of thiobarbituric acid–reactive substances, the change in the electrophoretic mobility of LDL, and the uptake of LDL by macrophages. When LDL oxidation was promoted by copper ions, the reaction was found to be inhibited by nitecapone added in a three- to five-molar excess of the concentration of copper ions. The mechanism by which nitecapone exerted its antioxidative effect in copper-mediated LDL oxidation depended on binding and redox inactivation of the copper ions. Moreover, nitecapone released LDL-bound copper ions and so rendered the LDL particles more resistant to oxidation. In contrast to a water-soluble -tocopherol analogue that was rapidly consumed during the oxidative process, nitecapone retained its inhibitory effect for at least 2 days. Using immobilized metal ion affinity chromatography, we showed that nitecapone binds both copper and iron ions, whereas its affinity for zinc ions is low. Nitecapone also inhibited LDL oxidation in the free radical–mediated oxidation system (AAPH). In this system, nitecapone showed synergistic antioxidative action with ascorbic acid. Finally, nitecapone inhibited macrophage-mediated LDL oxidation. Accordingly, nitecapone appears to have a unique antioxidative profile in that it both selectively chelates pro-oxidative transition metals and scavenges free radicals. Moreover, nitecapone has the potential of protecting LDL from oxidation in more complex biological in vitro systems in which multiple modes of oxidative stress act simultaneously, suggesting that this new compound, already tested in humans for its ability to inhibit catechol-O-methyltransferase activity, could potentially be used as an antioxidant drug.

Key Words: nitecapone • LDL • lipid peroxidation • atherosclerosis • macrophages

This article has been cited by other articles:

				M.-L. Silaste, M. Rantala, G. Alfthan, A. Aro, J. L. Witztum, Y. A. Kesaniemi, and S. Horkko Changes in Dietary Fat Intake Alter Plasma Levels of Oxidized Low-Density Lipoprotein and Lipoprotein(a) Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 498 - 503. [Abstract] [Full Text]

				M. O. Pentikainen, K. Oorni, and P. T. Kovanen Myeloperoxidase and Hypochlorite, but Not Copper Ions, Oxidize Heparin-Bound LDL Particles and Release Them From Heparin Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 1902 - 1908. [Abstract] [Full Text] [PDF]

				A. Roland, R. A. Patterson, and D. S. Leake Measurement of Copper-Binding Sites on Low Density Lipoprotein Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 594 - 602. [Abstract] [Full Text] [PDF]

				M. Aviram, L. Dornfeld, M. Rosenblat, N. Volkova, M. Kaplan, R. Coleman, T. Hayek, D. Presser, and B. Fuhrman Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1062 - 1076. [Abstract] [Full Text] [PDF]

				S. Kapiotis, G. Sengoelge, M. Hermann, I. Held, C. Seelos, and B. M. K. Gmeiner Paracetamol Catalyzes Myeloperoxidase-Initiated Lipid Oxidation in LDL Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2855 - 2860. [Abstract] [Full Text]

				K. Oorni, M. O. Pentikainen, A. Annila, and P. T. Kovanen Oxidation of Low Density Lipoprotein Particles Decreases Their Ability to Bind to Human Aortic Proteoglycans. DEPENDENCE ON OXIDATIVE MODIFICATION OF THE LYSINE RESIDUES J. Biol. Chem., August 22, 1997; 272(34): 21303 - 21311. [Abstract] [Full Text] [PDF]